Clinical Immunology Review Series: An approach to the patient with angio-oedema

Clinical and Experimental Immunology

Volumn 155, Issue 3, 2009, Pages 367-377

  Grigoriadou, S ^a   Longhurst, H J ^a  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

Angio oedema; Angiotensin converting enzyme inhibitors; C1 inhibitor

Indexed keywords

ADRENALIN; BRADYKININ; COMPLEMENT COMPONENT C1S INHIBITOR; DANAZOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ICATIBANT; METHYLTESTOSTERONE; OXANDROLONE; RHUCIN; STANOZOLOL; TIBOLONE; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ANGIONEUROTIC EDEMA; CLARKSON SYNDROME; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DRUG WITHDRAWAL; EMERGENCY CARE; FAMILY HISTORY; GLEICH SYNDROME; HUMAN; IMMUNOPATHOLOGY; NODULE EOSINOPHILIA RHEUMATISM DERMATITIS AND SWELLING SYNDROME; PATHOPHYSIOLOGY; PATIENT MONITORING; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN DEFICIENCY; REVIEW; TREATMENT RESPONSE;

ANDROGENS; ANGIOEDEMA; ANTIFIBRINOLYTIC AGENTS; COMPLEMENT C1 INHIBITOR PROTEIN; DIAGNOSIS, DIFFERENTIAL; HISTAMINE; HISTAMINE ANTAGONISTS; HUMANS;

EID: 59249087443     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2008.03845.x     Document Type: Review

References (126)

1. Deacock SJ. An approach to the patient with urticaria. Clin Exp Immunol 2008 153 : 151 61.
2. Schwartz LB, Metcalfe DD, Miller JS, Earl H, Sullivan T. Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med 1987 316 : 1622 6.
3. Watkins J. Markers and mechanisms of anaphylactoid reactions. Monogr Allergy 1992 30 : 108 29.
4. Byrd JB, Touzin K, Sile S et al. Dipeptidyl peptidase IV in angiotensin-converting enzyme inhibitor associated angioedema. Hypertension 2008 51 : 141 7.
5. Campos MM, Calixto JB. Neurokinin mediation of edema and inflammation. Neuropeptides 2000 34 : 314 22.
6. Kopp UC, Farley DM, Smith LA. Bradykinin-mediated activation of renal sensory neurons due to prostaglandin-dependent release of substance P. Am J Physiol 1997 272 : R2009 16.
7. Stevenson DD. Aspirin and NSAID sensitivity. Immunol Allergy Clin North Am 2004 24 : 491 505, vii.
8. Blanch A, Roche O, Urrutia I, Gamboa P, Fontan G, Lopez-Trascasa M. First case of homozygous C1 inhibitor deficiency. J Allergy Clin Immunol 2006 118 : 1330 5.
9. Davis AE III. The pathophysiology of hereditary angioedema. Clin Immunol 2005 114 : 3 9.
10. Nussberger J, Cugno M, Amstutz C, Cicardi M, Pellacani A, Agostoni A. Plasma bradykinin in angio-oedema. Lancet 1998 351 : 1693 7.
11. Nussberger J, Cugno M, Cicardi M, Agostoni A. Local bradykinin generation in hereditary angioedema. J Allergy Clin Immunol 1999 104 : 1321 2.
12. Nussberger J, Cugno M, Cicardi M. Bradykinin-mediated angioedema. N Engl J Med 2002 347 : 621 2.
13. Pappalardo E, Zingale LC, Terlizzi A, Zanichelli A, Folcioni A, Cicardi M. Mechanisms of C1-inhibitor deficiency. Immunobiology 2002 205 : 542 51.
14. Khan S, Tarzi MD, Dore PC, Sewell WA, Longhurst HJ. Secondary systemic lupus erythematosus: an analysis of 4 cases of uncontrolled hereditary angioedema. Clin Immunol 2007 123 : 14 17.
15. Zahedi R, Bissler JJ, Davis AE III., Andreadis C, Wisnieski JJ. Unique C1 inhibitor dysfunction in a kindred without angioedema. II. Identification of an Ala443→Val substitution and functional analysis of the recombinant mutant protein. J Clin Invest 1995 95 : 1299 305
16. Bork K, Staubach P, Eckardt AJ, Hardt J. Symptoms, course, and complications of abdominal attacks in hereditary angioedema due to C1 inhibitor deficiency. Am J Gastroenterol 2006 101 : 619 27.
17. Bork K, Meng G, Staubach P, Hardt J. Hereditary angioedema: new findings concerning symptoms, affected organs, and course. Am J Med 2006 119 : 267 74.
18. Agostoni A, Cicardi M. Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients. Medicine (Baltimore) 1992 71 : 206 15.
19. Farkas H, Harmat G, Kaposi PN et al. Ultrasonography in the diagnosis and monitoring of ascites in acute abdominal attacks of hereditary angioneurotic oedema. Eur J Gastroenterol Hepatol 2001 13 : 1225 30.
20. Bork K, Barnstedt SE. Laryngeal edema and death by asphyxiation following tooth extraction in four patients with hereditary angioedema. J Am Dent Assoc 2003 134 : 1088 94.
21. Bork K, Siedlecki K, Bosch S, Schopf RE, Kreuz W. Asphyxiation by laryngeal edema in patients with hereditary angioedema. Mayo Clin Proc 2000 75 : 349 54.
22. Bork K, Hardt J, Schicketanz KH, Ressel N. Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency. Arch Intern Med 2003 163 : 1229 35.
23. Visy B, Fust G, Bygum A et al. Helicobacter pylori infection as a triggering factor of attacks in patients with hereditary angioedema. Helicobacter 2007 12 : 251 7.
24. Farkas H, Csepregi A, Nemesanszky E et al. Acquired angioedema associated with chronic hepatitis C. J Allergy Clin Immunol 1999 103 : 711 12.
25. Bork K, Fischer B, Dewald G. Recurrent episodes of skin angioedema and severe attacks of abdominal pain induced by oral contraceptives or hormone replacement therapy. Am J Med 2003 114 : 294 8.
26. Bork K, Barnstedt SE, Koch P, Traupe H. Hereditary angioedema with normal C1-inhibitor activity in women. Lancet 2000 356 : 213 17.
27. Binkley KE, Davis A III. Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedema. J Allergy Clin Immunol 2000 106 : 546 50.
28. Bork K, Gul D, Hardt J, Dewald G. Hereditary angioedema with normal C1 inhibitor: clinical symptoms and course. Am J Med 2007 120 : 987 92.
29. Bork K, Dewald G. Hereditary angioedema type III, angioedema associated with angiotensin II receptor antagonists, and female sex. Am J Med 2004 116 : 644 5.
30. Bork K, Gul D, Dewald G. Hereditary angio-oedema with normal C1 inhibitor in a family with affected women and men. Br J Dermatol 2006 154 : 542 5.
31. Martin L, Raison-Peyron N, Nothen MM, Cichon S, Drouet C. Hereditary angioedema with normal C1 inhibitor gene in a family with affected women and men is associated with the p.Thr328Lys mutation in the F12 gene. J Allergy Clin Immunol 2007 120 : 975 7.
32. Bouillet L, Ponard D, Rousset H, Cichon S, Drouet C. A case of hereditary angio-oedema type III presenting with C1-inhibitor cleavage and a missense mutation in the F12 gene. Br J Dermatol 2007 156 : 1063 5.
33. Bork K. Hereditary angioedema with normal C1 inhibitor activity including hereditary angioedema with coagulation factor XII gene mutations. Immunol Allergy Clin North Am 2006 26 : 709 24.
34. Dewald G, Bork K. Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor. Biochem Biophys Res Commun 2006 343 : 1286 9.
35. Cichon S, Martin L, Hennies HC et al. Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III. Am J Hum Genet 2006 79 : 1098 104.
36. Zingale LC, Castelli R, Zanichelli A, Cicardi M. Acquired deficiency of the inhibitor of the first complement component: presentation, diagnosis, course, and conventional management. Immunol Allergy Clin North Am 2006 26 : 669 90.
37. Castelli R, Deliliers DL, Zingale LC, Pogliani EM, Cicardi M. Lymphoproliferative disease and acquired C1 inhibitor deficiency. Haematologica 2007 92 : 716 18.
38. Alsenz J, Bork K, Loos M. Autoantibody-mediated acquired deficiency of C1 inhibitor. N Engl J Med 1987 316 : 1360 6.
39. Barilla-LaBarca ML, Gioffre D, Zanichelli A, Cicardi M, Atkinson JP. Acquired C1 esterase inhibitor deficiency in two patients presenting with a lupus-like syndrome and anticardiolipin antibodies. Arthritis Rheum 2002 47 : 223 6.
40. Farkas H, Szongoth M, Bely M et al. Angiooedema due to acquired deficiency of C1-esterase inhibitor associated with leucocytoclastic vasculitis. Acta Derm Venereol 2001 81 : 298 300.
41. Asero R, Riboldi P, Tedeschi A, Cugno M, Meroni P. Chronic urticaria: a disease at a crossroad between autoimmunity and coagulation. Autoimmun Rev 2007 7 : 71 6.
42. Kozel MM, Mekkes JR, Bossuyt PM, Bos JD. Natural course of physical and chronic urticaria and angioedema in 220 patients. J Am Acad Dermatol 2001 45 : 387 91.
43. Champion RH, Roberts SO, Carpenter RG, Roger JH. Urticaria and angio-oedema. A review of 554 patients. Br J Dermatol 1969 81 : 588 97.
44. Zingale LC, Beltrami L, Zanichelli A et al. Angioedema without urticaria: a large clinical survey. Can Med Assoc J 2006 175 : 1065 70.
45. Adam A, Cugno M, Molinaro G, Perez M, Lepage Y, Agostoni A. Aminopeptidase P in individuals with a history of angio-oedema on ACE inhibitors. Lancet 2002 359 : 2088 9.
46. Blais C Jr., Brown JL, Rouleau NJ et al. Serum metabolism of bradykinin and des-Arg9-bradykinin in patients with angiotensin-converting enzyme inhibitor-associated angioedema. Immunopharmacology 1999 43 : 293 302.
47. Russell JS, Chi H, Lantry LE, Stephens RE, Ward PE. Substance P and neurokinin A metabolism by cultured human skeletal muscle myocytes and fibroblasts. Peptides 1996 17 : 1397 403.
48. Mullins RJ, Shanahan TM, Dobson RT. Visceral angioedema related to treatment with an ACE inhibitor. Med J Aust 1996 165 : 319 21.
49. Orr KK, Myers JR. Intermittent visceral edema induced by long-term enalapril administration. Ann Pharmacother 2004 38 : 825 7.
50. Dean DE, Schultz DL, Powers RH. Asphyxia due to angiotensin converting enzyme (ACE) inhibitor mediated angioedema of the tongue during the treatment of hypertensive heart disease. J Forensic Sci 2001 46 : 1239 43.
51. Jason DR. Fatal angioedema associated with captopril. J Forensic Sci 1992 37 : 1418 21.
52. Oike Y, Ogata Y, Higashi D, Matsumura T, Numata Y. Fatal angioedema associated with enalapril. Intern Med 1993 32 : 308 10.
53. Slater EE, Merrill DD, Guess HA et al. Clinical profile of angioedema associated with angiotensin converting-enzyme inhibition. JAMA 1988 260 : 967 70.
54. Ulmer JL, Garvey MJ. Fatal angioedema associated with lisinopril. Ann Pharmacother 1992 26 : 1245 6.
55. Agostoni A, Cicardi M. Drug-induced angioedema without urticaria. Drug Saf 2001 24 : 599 606.
56. Brown NJ, Snowden M, Griffin MR. Recurrent angiotensin-converting enzyme inhibitor - associated angioedema. JAMA 1997 278 : 232 3.
57. Cameron HA, Higgins TJ. Clinical experience with lisinopril. Observations on safety and tolerability. J Hum Hypertens 1989 3 (Suppl. 1 177 86.
58. Sica DA. The African American Study of Kidney Disease and Hypertension (AASK) trial: what more have we learned? J Clin Hypertens (Greenwich) 2003 5 : 159 67.
59. Kostis JB, Packer M, Black HR, Schmieder R, Henry D, Levy E. Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial. Am J Hypertens 2004 17 : 103 11.
60. Brown NJ, Ray WA, Snowden M, Griffin MR. Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema. Clin Pharmacol Ther 1996 60 : 8 13.
61. Gibbs CR, Lip GY, Beevers DG. Angioedema due to ACE inhibitors: increased risk in patients of African origin. Br J Clin Pharmacol 1999 48 : 861 5.
62. Lefebvre J, Murphey LJ, Hartert TV, Jiao SR, Simmons WH, Brown NJ. Dipeptidyl peptidase IV activity in patients with ACE-inhibitor-associated angioedema. Hypertension 2002 39 : 460 4.
63. Morimoto T, Gandhi TK, Fiskio JM et al. An evaluation of risk factors for adverse drug events associated with angiotensin-converting enzyme inhibitors. J Eval Clin Pract 2004 10 : 499 509.
64. Gabb GM, Ryan P, Wing LM, Hutchinson KA. Epidemiological study of angioedema and ACE inhibitors. Aust N Z J Med 1996 26 : 777 82.
65. Kyrmizakis DE, Papadakis CE, Liolios AD et al. Angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists. Arch Otolaryngol Head Neck Surg 2004 130 : 1416 19.
66. Schiller PI, Messmer SL, Haefeli WE, Schlienger RG, Bircher AJ. Angiotensin-converting enzyme inhibitor-induced angioedema: late onset, irregular course, and potential role of triggers. Allergy 1997 52 : 432 5.
67. Kostis JB, Kim HJ, Rusnak J et al. Incidence and characteristics of angioedema associated with enalapril. Arch Intern Med 2005 165 : 1637 42.
68. Bas M, Kojda G, Bier H, Hoffmann TK ACE inhibitor-induced angioedema in the head and neck region. A matter of time? HNO 2004 52 : 886 90.
69. Gleich GJ, Schroeter AL, Marcoux JP, Sachs MI, O'Connell EJ, Kohler PF. Episodic angioedema associated with eosinophilia. N Engl J Med, 1984 310 : 1621 6.
70. Emonet S, Kaya G, Hauser C. Gleich's syndrome Ann Dermatol Venereol 2000 127 : 616 18.
71. Chikama R, Hosokawa M, Miyazawa T, Miura R, Suzuki T, Tagami H. Nonepisodic angioedema associated with eosinophilia: report of 4 cases and review of 33 young female patients reported in Japan. Dermatology 1998 197 : 321 5.
72. Shimasaki AK Five cases of nonepisodic angioedema with eosinophilia Rinsho Ketsueki 2001 42 : 639 43.
73. Butterfield JH, Leiferman KM, Gleich GJ. Nodules, eosinophilia, rheumatism, dermatitis and swelling (NERDS): a novel eosinophilic disorder. Clin Exp Allergy 1993 23 : 571 80.
74. Clarkson B, Thompson D, Horwith M, Luckey EH. Cyclical edema and shock due to increased capillary permeability. Am J Med 1960 29 : 193 216.
75. Tahirkheli NK, Greipp PR. Treatment of the systemic capillary leak syndrome with terbutaline and theophylline A case series. Ann Intern Med 1999 130 : 905 9.
76. Airaghi L, Montori D, Santambrogio L, Miadonna A, Tedeschi A. Chronic systemic capillary leak syndrome Report of a case and review of the literature. J Intern Med 2000 247 : 731 5.
77. Sundin DJ, Wolin MJ. Toxicity management in patients receiving low-dose aldesleukin therapy. Ann Pharmacother 1998 32 : 1344 52.
78. Guillot B, Blazquez L, Bessis D, Dereure O, Guilhou JJ. A prospective study of cutaneous adverse events induced by low-dose alpha-interferon treatment for malignant melanoma. Dermatology 2004 208 : 49 54.
79. Kaplan AP. Clinical practice. Chronic urticaria and angioedema. N Engl J Med 2002 346 : 175 9.
80. Tosi M. Molecular genetics of C1 inhibitor. Immunobiology 1998 358 65.
81. Wisnieski JJ, Baer AN, Christensen J et al. Hypocomplementemic urticarial vasculitis syndrome. Clinical and serologic findings in 18 patients. Medicine (Baltimore) 1995 74 : 24 41.
82. Gompels MM, Lock RJ. Laboratory testing for C1 inhibitor deficiency: a comparison of two approaches to C1 inhibitor function. Ann Clin Biochem 2007 44 : 75 8.
83. Tarzi MD, Hickey A, Forster T, Mohammadi M, Longhurst HJ. An evaluation of tests used for the diagnosis and monitoring of C1 inhibitor deficiency: normal serum C4 does not exclude hereditary angio-oedema. Clin Exp Immunol 2007 149 : 513 16.
84. Karim Y, Griffiths H, Deacock S. Normal complement C4 values do not exclude hereditary angioedema. J Clin Pathol 2004 57 : 213 14.
85. Lean-Tooke A, Stroud C, Sampson A, Spickett G. Falsely normal C4 in a case of acquired C1 esterase inhibitor deficiency. J Clin Pathol 2007 60 : 565 6.
86. Wiltshire A, Whitfield P, Wild G, Egner W. C1-esterase inhibitor functional assay degradation study. Institute of Biomedical Scientists Congress, Birmingham, September 2007.
87. Wagenaar-Bos IG, Drouet C, Ygoren-Pursun E et al. Functional C1-inhibitor diagnostics in hereditary angioedema: assay evaluation and recommendations. J Immunol Methods 2008 338 : 14 20.
88. Wagenaar-Bos IG, Hack CE. Structure and function of C1-inhibitor. Immunol Allergy Clin North Am 2006 26 : 615 32.
89. Bowen T, Cicardi M, Farkas H et al. Canadian 2003 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema. J Allergy Clin Immunol 2004 114 : 629 37.
90. Bowen T, Cicardi M, Bork K et al. Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema. Ann Allergy Asthma Immunol 2008 100 : S30 S40.
91. Gompels MM, Lock RJ, Abinun M et al. C1 inhibitor deficiency: consensus document. Clin Exp Immunol 2005 139 : 379 94.
92. Kunschak M, Engl W, Maritsch F et al. A randomized, controlled trial to study the efficacy and safety of C1 inhibitor concentrate in treating hereditary angioedema. Transfusion 1998 38 : 540 9.
93. Waytes AT, Rosen FS, Frank MM. Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate. N Engl J Med 1996 334 : 1630 4.
94. Bork K. Pasteurised C1 inhibitor concentrate: pharmacology, efficacy, safety and future directions. Expert Rev Clin Immunol 2008 13 20.
95. Bork K, Barnstedt SE. Treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedema. Arch Intern Med 2001 161 : 714 18.
96. Bork K, Meng G, Staubach P, Hardt J. Treatment with C1 inhibitor concentrate in abdominal pain attacks of patients with hereditary angioedema. Transfusion 2005 45 : 1774 84.
97. Pekdemir M, Ersel M, Aksay E, Yanturali S, Akturk A, Kiyan S. Effective treatment of hereditary angioedema with fresh frozen plasma in an emergency department. J Emerg Med 2007 33 : 137 9.
98. Longhurst HJ. Emergency treatment of acute attacks in hereditary angioedema due to C1 inhibitor deficiency: what is the evidence? Int J Clin Pract 2005 59 : 594 9.
99. Blohme G. Treatment of hereditary angioneurotic oedema with tranexamic acid A random double-blind cross-over study. Acta Med. Scand 1972 192 : 293 8.
100. Bork K, Frank J, Grundt B, Schlattmann P, Nussberger J, Kreuz W. Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant). J Allergy Clin Immunol 2007 119 : 1497 503.
101. Choi G, Soeters MR, Farkas H et al. Recombinant human C1-inhibitor in the treatment of acute angioedema attacks. Transfusion 2007 47 : 1028 32.
102. Longhurst H. Rhucin, a recombinant C1 inhibitor for the treatment of hereditary angioedema and cerebral ischemia. Curr Opin Investig Drugs 2008 9 : 310 23.
103. Schneider L, Lumry W, Vegh A, Williams AH, Schmalbach T. Critical role of kallikrein in hereditary angioedema pathogenesis: a clinical trial of ecallantide, a novel kallikrein inhibitor. J Allergy Clin Immunol 2007 120 : 416 22.
104. Levy JH, O'Donnell PS. The therapeutic potential of a kallikrein inhibitor for treating hereditary angioedema. Expert Opin Invest Drugs 2006 15 : 1077 90.
105. Davis AE III. The pathophysiology of hereditary angioedema. Clin Immunol 2005 114 : 3 9.
106. Cicardi M, Zingale L, Zanichelli A, Deliliers DL. Established and new treatments for hereditary angioedema: an update. Mol Immunol 2007 44 : 3858 61.
107. Lock RJ, Gompels MM. C1-inhibitor deficiencies (hereditary angioedema): where are we with therapies? Curr Allergy Asthma Rep 2007 7 : 264 9.
108. Gelfand JA, Sherins RJ, Alling DW, Frank MM. Treatment of hereditary angioedema with danazol Reversal of clinical and biochemical abnormalities. N Engl J Med 1976 295 : 1444 8.
109. Sheffer AL, Fearon DT, Austen KF. Clinical and biochemical effects of stanozolol therapy for hereditary angioedema. J Allergy Clin Immunol 1981 68 : 181 7.
110. Barakat AJ, Castaldo AJ. Successful use of oxandrolone in the prophylaxis of hereditary angioedema: a case report. Pediatric Asthma, Allergy and Immunology 1999 189 93.
111. Ott HW, Mattle V, Hadziomerovic D et al. Treatment of hereditary angioneurotic oedema (HANE) with tibolone. Clin Endocrinol (Oxf) 2007 66 : 180 4.
112. Cicardi M, Castelli R, Zingale LC, Agostoni A. Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: comparison of treated and untreated patients. J Allergy Clin Immunol 1997 99 : 194 6.
113. Banerji A, Sloane DE, Sheffer AL. Hereditary angioedema: a current state-of-the-art review, V: attenuated androgens for the treatment of hereditary angioedema. Ann Allergy Asthma Immunol 2008 100 : S19 S22.
114. Bork K, Schneiders V. Danazol-induced hepatocellular adenoma in patients with hereditary angio-oedema. J Hepatol 2002 36 : 707 9.
115. Frank M, Gelfand JA, Alling DW, Sherins RJ. Epsilon aminocaproic acid for hereditary angioedema. N Engl J Med 1977 296 : 1235 6.
116. Levi M, Choi G, Picavet C, Hack CE. Self-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiency. J Allergy Clin Immunol 2006 117 : 904 8.
117. Longhurst HJ, Carr S, Khair K. C1-inhibitor concentrate home therapy for hereditary angioedema: a viable, effective treatment option. Clin Exp Immunol 2007 147 : 11 17.
118. Bork K, Witzke G. Long-term prophylaxis with C1-inhibitor (C1 INH) concentrate in patients with recurrent angioedema caused by hereditary and acquired C1-inhibitor deficiency. J Allergy Clin Immunol 1989 83 : 677 82.
119. Levi M, Hack CE, van Oers MH. Rituximab-induced elimination of acquired angioedema due to C1-inhibitor deficiency. Am J Med 2006 119 : e3 5.
120. Powell RJ, Du Toit GL, Siddique N et al. BSACI guidelines for the management of chronic urticaria and angio-oedema. Clin Exp Allergy 2007 37 : 631 50.
121. Grattan C, Powell S, Humphreys F. Management and diagnostic guidelines for urticaria and angio-oedema. Br J Dermatol 2001 144 : 708 14.
122. Bas M, Adams V, Suvorava T, Niehues T, Hoffmann TK, Kojda G. Nonallergic angioedema: role of bradykinin. Allergy 2007 62 : 842 56.
123. Karim MY, Masood A. Fresh-frozen plasma as a treatment for life-threatening ACE-inhibitor angioedema. J Allergy Clin Immunol 2002 109 : 370 1.
124. Cicardi M, Zingale LC, Bergamaschini L, Agostoni A. Angioedema associated with angiotensin-converting enzyme inhibitor use: outcome after switching to a different treatment. Arch Intern Med 2004 164 : 910 13.
125. Kyrmizakis DE, Papadakis CE, Liolios AD et al. Angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists. Arch Otolaryngol Head Neck Surg 2004 130 : 1416 19.
126. Nielsen EW, Gramstad S. Angioedema from angiotensin-converting enzyme (ACE) inhibitor treated with complement 1 (C1) inhibitor concentrate. Acta Anaesthesiol Scand 2006 50 : 120 2.